Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001104659-23-066205
Filing Date
2023-05-31
Accepted
2023-05-30 18:50:52
Documents
16
Period of Report
2022-12-31

Document Format Files

Seq Description Document Type Size
1 10-K/A tm2316662d1_10ka.htm   iXBRL 10-K/A 42227
2 EXHIBIT 23.1 tm2316662d1_ex23-1.htm EX-23.1 2968
3 EXHIBIT 31.1 tm2316662d1_ex31-1.htm EX-31.1 10296
4 EXHIBIT 31.2 tm2316662d1_ex31-2.htm EX-31.2 10102
8 GRAPHIC tm2316662d1_ex23-1img001.jpg GRAPHIC 2134
  Complete submission text file 0001104659-23-066205.txt   292342

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA mist-20221231.xsd EX-101.SCH 3054
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE mist-20221231_lab.xml EX-101.LAB 36509
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mist-20221231_pre.xml EX-101.PRE 24012
10 EXTRACTED XBRL INSTANCE DOCUMENT tm2316662d1_10ka_htm.xml XML 5832
Mailing Address 1111 BOUL. DR.-FREDERIK-PHILIPS, STE 420 MONTREAL A8 H4M 2X6
Business Address 1111 BOUL. DR.-FREDERIK-PHILIPS, STE 420 MONTREAL A8 H4M 2X6 (514) 336-0444
Milestone Pharmaceuticals Inc. (Filer) CIK: 0001408443 (see all company filings)

EIN.: 000000000 | State of Incorp.: A8 | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-38899 | Film No.: 23978369
SIC: 2834 Pharmaceutical Preparations